Potent inhibitors of protein farnesyltransferase: Heteroarenes as cysteine replacements
- 1 March 1999
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 9 (5) , 703-708
- https://doi.org/10.1016/s0960-894x(99)00080-3
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Non-Ras targets of farnesyltransferase inhibitors: focus on RhoOncogene, 1998
- A Farnesyl-Protein Transferase Inhibitor Induces p21 Expression and G1 Block in p53 Wild Type Tumor CellsJournal of Biological Chemistry, 1998
- N-Arylalkyl Pseudopeptide Inhibitors of FarnesyltransferaseJournal of Medicinal Chemistry, 1998
- Farnesyltransferase inhibitors:a cell signalling approach to the design of efficacious anticancer agentsEmerging Drugs, 1998
- Inhibitors of protein farnesylation 1998Expert Opinion on Therapeutic Patents, 1998
- Potent, Selective, and Orally Bioavailable Tricyclic Pyridyl Acetamide N-Oxide Inhibitors of Farnesyl Protein Transferase with Enhanced in Vivo Antitumor ActivityJournal of Medicinal Chemistry, 1998
- Pre-clinical development of farnesyltransferase inhibitors.Cancer and Metastasis Reviews, 1998
- A New Class of Highly Potent Farnesyl Diphosphate-Competitive Inhibitors of FarnesyltransferaseJournal of Medicinal Chemistry, 1998
- C-Terminal Modifications of Histidyl-N-benzylglycinamides To Give Improved Inhibition of Ras Farnesyltransferase, Cellular Activity, and Anticancer Activity in MiceJournal of Medicinal Chemistry, 1997
- PROTEIN PRENYLATION: Molecular Mechanisms and Functional ConsequencesAnnual Review of Biochemistry, 1996